Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000694414 | SCV000822859 | pathogenic | GM3 synthase deficiency | 2024-02-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp49*) in the ST3GAL5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ST3GAL5 are known to be pathogenic (PMID: 15502825, 22990144, 27232954). This variant is present in population databases (rs778265926, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with ST3GAL5-related conditions. ClinVar contains an entry for this variant (Variation ID: 572904). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV002245597 | SCV002513753 | likely pathogenic | not provided | 2022-05-11 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV000694414 | SCV005656877 | likely pathogenic | GM3 synthase deficiency | 2024-04-05 | criteria provided, single submitter | clinical testing |